Nature of Disclosure: Regulatory intimation of upcoming board meeting for quarterly financial results approval, submitted to BSE Limited.
Board Meeting Details: The Meeting of Board of Directors is scheduled to be held on Monday, 20th July, 2026. The agenda includes:
- Consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026
- Consider and approve the Limited Review Report on the financial results
- Consider other routine matters with the permission of chair
Regulatory Compliance: The disclosure is made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will submit the financial results in both XBRL mode (using the exchange-provided excel template) and PDF mode within the prescribed time limit.
Trading Window Update: In continuation of the earlier disclosure dated 25th June, 2026 and pursuant to the Company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the company's securities shall open after 48 hours of the declaration of Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026. This applies to all designated persons, their immediate relatives, and all connected persons covered under the code.